Vetera 4XP + WNVThis page contains information on Vetera 4XP + WNV for veterinary use.
The information provided typically includes the following:
- Vetera 4XP + WNV Indications
- Warnings and cautions for Vetera 4XP + WNV
- Direction and dosage information for Vetera 4XP + WNV
Vetera 4XP + WNVThis treatment applies to the following species:
Encephalomyelitis-Influenza-West Nile Virus Vaccine
Eastern & Western, Killed Virus
Vetera 4XP + WNV Indications
For vaccination of healthy horses 4 months of age or older, including pregnant mares, as an aid in the prevention of disease caused by Eastern and Western Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; and as an aid in the reduction of respiratory disease and shedding caused by A2 Equine Influenza virus. Product contains Kentucky Lineage (KY/95), Florida sublineage clade 1 (OH/03), and Florida sublineage clade 2 (RI/07) equine influenza strains. Efficacy (DOI) has been demonstrated for at least 6 months against OH/03. The duration of immunity against West Nile Virus is at least 12 months.
Administration and dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure with a single 1 mL intramuscular dose.
PrecautionsStore at 35-45°F (2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.
This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.
Preservatives: Gentamicin and Amphotericin B.
For Veterinary Use Only
Vetera® is a registered trademark of Boehringer Ingelheim Vetmedica GmbH. Used under license.
© 2015 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506
US Vet. Lic. No. 124
US Patent Nos. 7572620, 8535685, 8697089, 8784838, and 8821889.
1 Dose/1 mL
10 Doses/10 mL
3239 SATELLITE BLVD., DULUTH, GA, 30096
|Every effort has been made to ensure the accuracy of the Vetera 4XP + WNV information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2018 North American Compendiums. Updated: 2018-03-29